You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SPNS2 inhibitors as renal fibrosis therapy
SBC: Flux Therapeutics, LLC Topic: 400Fibrosis is an aberrant wound healing process characterized by progressive accumulation of extracellular matrix that ultimately destroys organ function. Progressive fibrosis is inherent to chronic kidney disease (CKD), which often leads to end-stage renal disease. Although patients can be maintained by hemodialysis while awaiting transplantation, their’s and their care-giver’s quality of life ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Feasibility of app-delivered circadian synchronization therapy with light in a cohort of pregnant women
SBC: ARCASCOPE INC. Topic: NICHDPROJECT SUMMARY Circadian rhythms play a vital role in promoting maternal health and managing pregnancy outcomes, including gestational diabetes, preterm birth, and postpartum depression. However, interventions to mitigate circadian rhythms disruption during pregnancy are lacking, despite readily available non-pharmacological circadian interventions. The circadian timekeeping system is strengthene ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Impact VR: An Emotion Recognition and Regulation Training Program for Youth with Conduct Disorder
SBC: ARCHE VR LLC Topic: 104ABSTRACT Conduct disorder (CD) remains one of the most common, impairing, and costliest psychiatric disorders among youth. Youth with CD often face lifelong adjustment, mental health, legal, social, occupational, and physical health problems. A subset of youth with CD display callous-unemotional (CU) traits. Youth with CD and CU traits are more likely to engage in chronic criminal behaviors and de ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Improved Patient Reported Outcomes (iPRO)-Sleep Diary: A Tool to Improve Sleep Assessment in Clinical Trials
SBC: D-PRIME LLC Topic: NHLBIAbstract Insomnia is a highly prevalent condition that significantly degrades the quality of life and health of millions of patients. By diagnostic definition, insomnia is a disease characterized by self-reported subjective criteria, thus therapeutic developers targeting insomnia typically evaluate their treatment’s efficacy based on patient reported outcomes in the form of sleep diaries. A crit ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Novel Sample Introduction Methodologies for Molecular Rotational Resonance (MRR) Spectroscopy
SBC: BrightSpec, Inc. Topic: 400BrightSpec Inc. NIH SBIR Application Project Summary Novel Sample Introduction Methodologies for Molecular Rotational Resonance (MRR) Spectroscopy NIH SBIR Direct to Phase II BrightSpec, Inc. Project Summary This project proposes to develop a new analyte sampling technique for Molecular Rotational Resonance (MRR) spectrometers for the volatilization of solid phase analytes. The proposed system, La ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Clinical study to enable commercialization of nonsurgical gel patch for eardrum repair
SBC: TYMPANOGEN, INC. Topic: NIDCDABSTRACT Chronic perforations of the tympanic membrane (TM) affect over 170,000 patients in the United States annually, often stemming from ventilation tubes inserted in the TM to drain fluid from middle ear infections. Left untreated, these TM perforations can lead to significant morbidities that include recurrent ear infection, conductive and sensorineural hearing loss, mastoid bone infection, a ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy (KneeBRIGHT)
SBC: BARRON ASSOCIATES, INC. Topic: NIAPROJECT SUMMARY/ABSTRACT Significance: The Knee Biofeedback Rehabilitation Interface for Game-based Home Therapy (“KneeBRIGHT”) system combines electromyography (EMG) biofeedback with video game therapy (VGT) to provide knee osteoarthritis (OA) patients with an engaging, effective tool for conducting rehabilitation exercises at home. KneeBRIGHT aims to motivate OA patients to conduct regular m ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
PRECARE is an innovative and integrated platform designed to improve the developmental surveillance of the baby.
SBC: BENTEN TECHNOLOGIES, INC. Topic: NICHDProject SummaryIn the US, over 63% of babies do not receive developmental surveillance. Furthermore, despite increased developmental surveillance, 10% or less of babies with developmental delays (DD) (approximately 140,000) are being correctly identified and receive the early intervention (EI) they need. Developmental surveillance can identify developmental delays (DD) to support early interventio ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Toward urinary catheterization with long-term resistance to bacterial colonization
SBC: WYNNVISION LLC Topic: 400PD/PI Kennard Brunson Project Summary Toward urinary catheterization with long-term resistance to bacterial colonization Problem: Catheter Associated Urinary Tract Infections (CAUTI) are one of the most common infections in hospitals and health care facilities. A study of urinary catheterisation involving over 9 million hospitalized patients found 12.9% were catheterised overall, but 72.9% were ca ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Designing safe, potent, and cost-effective small peptide erythropoietin analogs
SBC: Covenant Therapeutics LLC Topic: NHLBIRecombinant human erythropoietin (rhEpo) has proven to be an effective treatment of anemias, primarily those secondary to renal disease and malignancy. The cost of rhEpo therapy, the need for frequent parenteral administration, the development in some patients of anti-Epo antibodies, and an associated increase in thromboembolic events (relative risk ratio of 1.67) suggest a real need for a cheaper ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health